Javascript must be enabled to continue!
Application of Deferoxamine in Tissue Regeneration Attributed to Promoted Angiogenesis
View through CrossRef
Deferoxamine, an iron chelator used to treat diseases caused by excess iron, has had a Food and Drug Administration-approved status for many years. A large number of studies have confirmed that deferoxamine can reduce inflammatory response and promote angiogenesis. Blood vessels play a crucial role in sustaining vital life by facilitating the delivery of immune cells, oxygen, and nutrients, as well as eliminating waste products generated during cellular metabolism. Dysfunction in blood vessels may contribute significantly to the development of life-threatening diseases. Anti-angiogenesis therapy and pro-angiogenesis/angiogenesis strategies have been frequently recommended for various diseases. Herein, we describe the mechanism by which deferoxamine promotes angiogenesis and summarize its application in chronic wounds, bone repair, and diseases of the respiratory system. Furthermore, we discuss the drug delivery system of deferoxamine for treating various diseases, providing constructive ideas and inspiration for the development of new treatment strategies.
Title: Application of Deferoxamine in Tissue Regeneration Attributed to Promoted Angiogenesis
Description:
Deferoxamine, an iron chelator used to treat diseases caused by excess iron, has had a Food and Drug Administration-approved status for many years.
A large number of studies have confirmed that deferoxamine can reduce inflammatory response and promote angiogenesis.
Blood vessels play a crucial role in sustaining vital life by facilitating the delivery of immune cells, oxygen, and nutrients, as well as eliminating waste products generated during cellular metabolism.
Dysfunction in blood vessels may contribute significantly to the development of life-threatening diseases.
Anti-angiogenesis therapy and pro-angiogenesis/angiogenesis strategies have been frequently recommended for various diseases.
Herein, we describe the mechanism by which deferoxamine promotes angiogenesis and summarize its application in chronic wounds, bone repair, and diseases of the respiratory system.
Furthermore, we discuss the drug delivery system of deferoxamine for treating various diseases, providing constructive ideas and inspiration for the development of new treatment strategies.
Related Results
Advancements in diagnosis and treatment of Adenomyosis
Advancements in diagnosis and treatment of Adenomyosis
In this thesis, we aimed to study how we can improve the diagnosing of adenomyosis by imaging the uterus in part I, especially using ultrasound and considering the assessment of th...
Deferoxamine in the Treatment of Hemophilic Synovitis by Inhibiting Macrophage Iron Overload
Deferoxamine in the Treatment of Hemophilic Synovitis by Inhibiting Macrophage Iron Overload
Abstract
Hemophilia frequently results in intra-articular bleeding, leading to substantial iron accumulation in the synovium, which facilitates M1 macrophage polarization a...
Impact of hypoxia induced VEGF and its signaling during caudal fin regeneration in Zebrafish
Impact of hypoxia induced VEGF and its signaling during caudal fin regeneration in Zebrafish
ABSTRACT:Hypoxia is known to play important role during various cellular process, including regeneration. Regeneration is a complex process involving wound healing and tissue repai...
Biphasic Effects of Statins on Angiogenesis-Mediated Processes.
Biphasic Effects of Statins on Angiogenesis-Mediated Processes.
Abstract
Background: Statins inhibit HMG-CoA reductase, resulting in the reduction of cholesterol synthesis as well as isoprenoids that modulate various cell functio...
Bone Marrow Granulocytes Drive Vascular and Hematopoietic Regeneration
Bone Marrow Granulocytes Drive Vascular and Hematopoietic Regeneration
Abstract
In addition to eliminating host hematopoietic cells myeloablation also disrupts the blood vessels that sustain hematopoiesis. Regeneration of the bone marro...
Abstract 1799: The effect of dovitinib on angiogenesis in human neuroendocrine tumors
Abstract 1799: The effect of dovitinib on angiogenesis in human neuroendocrine tumors
Abstract
Background: Dovitinib is a potent oral inhibitor of multiple angiogenic factors, including receptor tyrosine kinases (RTKs) such as VEGFR1-3, PDGFRβ, and FG...
Three-dimensional induced pluripotent stem-cell models of human brain angiogenesis
Three-dimensional induced pluripotent stem-cell models of human brain angiogenesis
Abstract
Background: During brain development, chemical cues released by developing neurons, cellular signaling with pericytes, and mechanical cues within the brain extrace...

